Reckitt Benckiser plans December spin-off for pharma unit
The firm says investors will receive one share in the unit, to be known as Indivior Plc, for each share they own
London: Reckitt Benckiser Group Plc said the separation of its pharmaceutical division will take place through a distribution to existing shareholders next month.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more